Prevalence of depression and its associations with cardio-metabolic control in Aboriginal and Anglo-Celt patients with type 2 diabetes: The Fremantle Diabetes Study Phase II

被引:15
|
作者
Davis, Timothy M. E. [1 ]
Hunt, Kerry [1 ]
Bruce, David G. [1 ]
Starkstein, Sergio [2 ]
Skinner, Timothy [3 ]
McAullay, Daniel [4 ,5 ]
Davis, Wendy A. [1 ]
机构
[1] Univ Western Australia, Sch Med & Pharmacol, Fremantle Hosp, Fremantle, WA 6959, Australia
[2] Univ Western Australia, Sch Psychiat & Clin Neurosci, Fremantle Hosp, Fremantle, WA 6959, Australia
[3] Charles Darwin Univ, Sch Psychol & Clin Sci, Casuarina, NT, Australia
[4] Edith Cowan Univ, Kurongkurl Katitjin Ctr Indigenous Australian Edu, Mt Lawley, WA, Australia
[5] Australian Natl Univ, Australian Primary Hlth Care Res Inst, Canberra, ACT, Australia
基金
英国医学研究理事会;
关键词
Type; 2; diabetes; Depression; Aboriginal; Antidepressant treatment; Metabolic control; INDIGENOUS AUSTRALIAN POPULATIONS; SCREENING TOOL; HEALTH; RISK; COMPLICATIONS; DETERMINANTS; VALIDITY; ALCOHOL; PROFILE; PEOPLE;
D O I
10.1016/j.diabres.2014.12.014
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims: To determine the prevalence and associates of depression in Aboriginal and Anglo-Celt (AC) Australians with type 2 diabetes. Methods: Community-based patients were screened using the Patient Health Questionnaire (PHQ-9) as part of detailed assessment. The prevalence of any current depression, major depression and antidepressant use by racial group was compared after adjustment for age, sex, educational attainment and marital status. Multiple logistic regression was used to determine associates of current depression. Results: The 107 Aboriginal participants were younger (mean +/- SD 54.3 +/- 11.8 vs 67.2 +/- 10.6 years), less often male (34.6% vs 50.9%) and married (39.3% vs 61.7%), and more likely to smoke (44.6% vs 8.1%) than the 793 AC subjects (P <= 0.002). Fifty-two Aboriginal (48.5%) and 772 AC participants (97.4%) completed the PHQ-9; these Aboriginals had similar socio-demographic, anthropometric and diabetes-related characteristics to those without PHQ-9 data. A quarter of the Aboriginals had current depression vs 10.6% of ACs (P = 0.16), 15.4% vs 4.1% had major depression (P = 0.029), and 68.8% vs 29.7% had untreated depression (P = 0.032). Compared with non-depressed participants, patients with current depression were younger and more likely to smoke, to be overweight/obese and to have worse glycaemic control (P <= 0.024). Significant independent associates of current depression were educational attainment (inversely), smoking status, body mass index and fasting plasma glucose in the AC group and alcohol use in the Aboriginal group. Conclusions: Although prevalence of depression was not significantly increased in the Aboriginal patients, it was more likely to be major and untreated. Depression complicating type 2 diabetes is associated with adverse cardiovascular risk. (C) 2015 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:384 / 391
页数:8
相关论文
共 50 条
  • [21] Ultrasonographic assessment of joint pathology in type 2 diabetes and hyperuricemia: The Fremantle Diabetes Study Phase II
    Keen, Helen I.
    Davis, Wendy A.
    Latkovic, Erin
    Drinkwater, Jocelyn J.
    Nossent, Johannes
    Davis, Timothy M. E.
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2018, 32 (04) : 400 - 405
  • [22] The relationship between thyroid dysfunction, cardiovascular morbidity and mortality in type 2 diabetes: The Fremantle Diabetes Study Phase II
    Chubb, S. A. Paul
    Peters, Kirsten E.
    Bruce, David G.
    Davis, Wendy A.
    Davis, Timothy M. E.
    ACTA DIABETOLOGICA, 2022, 59 (12) : 1615 - 1624
  • [23] Retinopathy predicts stroke but not myocardial infarction in type 2 diabetes: the Fremantle Diabetes Study Phase II
    Drinkwater, Jocelyn J.
    Davis, Timothy M. E.
    Hellbusch, Valentina
    Turner, Angus W.
    Bruce, David G.
    Davis, Wendy A.
    CARDIOVASCULAR DIABETOLOGY, 2020, 19 (01)
  • [24] Incidence and predictors of vision loss complicating type 2 diabetes: The Fremantle Diabetes Study Phase II
    Drinkwater, Jocelyn J.
    Davis, Timothy M. E.
    Davis, Wendy A.
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2020, 34 (06)
  • [25] Pneumococcal vaccination and incident hospitalisation for pneumonia in type 2 diabetes: the Fremantle Diabetes Study Phase II
    Davis, Timothy M. E.
    Kauhanen, Jane
    Davis, Wendy A.
    INTERNAL MEDICINE JOURNAL, 2017, 47 (10) : 1206 - 1210
  • [26] Prevalence and prognostic implications of the metabolic syndrome in community-based patients with type 1 diabetes: The Fremantle Diabetes Study
    Davis, Timothy M. E.
    Bruce, David G.
    Davis, Wendy A.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2007, 78 (03) : 412 - 417
  • [27] Risk factors and outcomes of anxiety symptom trajectories in type 2 diabetes: the Fremantle Diabetes Study Phase II
    Whitworth, S. R.
    Bruce, D. G.
    Starkstein, S. E.
    Davis, T. M. E.
    Skinner, T. C.
    Davis, W. A.
    Bucks, R. S.
    DIABETIC MEDICINE, 2020, 37 (10) : 1688 - 1695
  • [28] Thyroid Hormones Protect Type 2 Diabetes Obese Patients Against Cardio-Metabolic Risk Factors
    Dezayee, Zhian M. I.
    Al-Nimer, Marwan S. M.
    JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2015, 5 (1-2) : 179 - 183
  • [29] Assessment of biomarkers associated with rapid renal decline in the detection of retinopathy and its progression in type 2 diabetes: The Fremantle Diabetes Study Phase II
    Drinkwater, Jocelyn J.
    Peters, Kirsten
    Davis, Wendy A.
    Turner, Angus W.
    Bringans, Scott D.
    Lipscombe, Richard J.
    Davis, Timothy M. E.
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2021, 35 (04)
  • [30] Validation of a protein biomarker test for predicting renal decline in type 2 diabetes: The Fremantle Diabetes Study Phase II
    Peters, Kirsten E.
    Davis, Wendy A.
    Ito, Jun
    Bringans, Scott D.
    Lipscombe, Richard J.
    Davis, Timothy M. E.
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2019, 33 (12)